PreveCeutical Announces Closing of Non-Brokered Private Placement
PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H) (the "Company" or "PreveCeutical") announces the closing of a non-brokered private placement financing (the...
Genetic Technologies Limited Announces Research Collaboration with Two Medical Centers
Genetic Technologies (NASDAQ:GENE,ASX:GTG) has announced a research agreement between its subsidiary, Phenogen, Memorial Sloan Kettering Cancer Center, New York and...
Editas Medicine Announces Publication in Nature Medicine of Data Supporting the Development of EDIT-101
Editas Medicine (Nasdaq:EDIT), a leading genome editing company, today announced the journal Nature Medicine published the comprehensive, pre-clinical data demonstrating the pharmacology...
HTG Launches HTG EdgeSeq Reveal
HTG Molecular Diagnostics (Nasdaq:HTGM) a life science company whose mission is to advance precision medicine, today announced the launch of the...
BeiGene Receives U.S. FDA Breakthrough Therapy Designation for Zanubrutinib
BeiGene (NASDAQ:BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly-targeted and immuno-oncology drugs for the...
HTG Molecular Announces Executive Transition Plan
HTG Molecular Diagnostics (Nasdaq:HTGM) a life science company whose mission is to advance precision medicine, announced a leadership transition plan in...
Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs
Mesoblast (ASX:MSB;Nasdaq:MESO) today announced that it has drawn down a further US$15 million from its US$75 million, non-dilutive, four-year credit...